Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeted therapy in acute myeloid leukemia: current status and new insights from a proteomic perspective

2 Jan 2020

Abstract excerpt

Introduction: The biological heterogeneity of acute myeloid leukemia (AML) complicates personalized medicine. Individual prognosis is typically based on the presence of chromosomal and genetic lesions. Nevertheless, these classifications often lack a priori information about response to therapy. Since the protein expression landscape reflects the functional activity state of cells, we hypothesize that analyzing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Advanced biosensing and bioanalysis techniques
Share to Protein Degradation and Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31945303
DOI: 10.1080/14789450.2020.1717951

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeted therapy in acute myeloid leukemia: current status and new insights from a proteomic perspectivePMID 31945303Read ↗

Proteomic Characterization of Acute Myeloid Leukemia for Precision MedicineSemantic proximity Read ↗

Functional proteomic profiling of AML predicts response and survivalSemantic proximity Read ↗

Molecular biomarkers in acute myeloid leukemia.Semantic proximity Read ↗

Proteomic approaches in myeloid leukemia.Semantic proximity Read ↗

A quantitative analysis of heterogeneities and hallmarks in acute myelogenous leukaemia.Semantic proximity Read ↗

Proteomic subtypes enrich current acute myeloid leukemia nomenclature and reflect intrinsic pathogenesis alongside agingSemantic proximity Read ↗

Molecular genetic pathways as therapeutic targets in acute myeloid leukemia.Semantic proximity Read ↗

Utilizing proteomics and phosphoproteomics to predict <i>ex vivo</i> drug sensitivity across genetically diverse AML patientsSemantic proximity Read ↗

Integrated OMICs unveil the bone-marrow microenvironment in human leukemiaSemantic proximity Read ↗

Quantitative proteomics reveals specific metabolic features of acute myeloid leukemia stem cellsSemantic proximity Read ↗

Proteomic and phosphoproteomic measurements enhance ability to predict ex vivo drug response in AMLSemantic proximity Read ↗

Mapping the proteogenomic landscape enables prediction of drug response in acute myeloid leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.